Abbott's hand-held blood analyzer grabs CE mark

abbott
Abbott's i-STAT Alinity System performs tests on a few drops of blood and delivers results in as few as two minutes.

Abbott secured a CE mark for its portable blood analyzer, which rapidly performs blood tests using two or three drops of blood. The hand-held device, which offers the largest range of blood tests on a single device, allows caregivers to make quick medical decisions at the point of care.

The i-STAT Alinity System returns results within two to 10 minutes and can run tests including blood chemistry and cardiac biomarkers, Abbott said in a statement. The device connects to healthcare systems’ networks so that providers can manage diagnostic data. It also connects to the cloud, facilitating the delivery of quality-control data, the company said.

"Whether in emergency departments, critical care settings or rural areas, i-STAT Alinity allows clinicians to make timely and informed treatment decisions that help people get back to better health,” said VP of Point of Care Diagnostics Sharon Bracken in the statement.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

As more and more people access healthcare, hospitals and health systems may struggle to keep up and find efficient, cost-effective ways to offer quality care, the company said. These include diagnostic tech that doesn’t necessitate extensive training. This is where Abbott’s device comes in: In designing the i-STAT Alinity, the company looked into the challenges that providers face while carrying out day-to-day point-of-care testing.

"We spent countless hours doing on-the-ground research with doctors, nurses, lab directors, point of care coordinators and other customers from around the world," said Matt Bates, divisional vice president of research and development at Abbott’s Point of Care Diagnostics division. "We asked about their pain points and listened to what they want and need for testing. Using these customer insights, Abbott designed and built i-STAT Alinity for better access, efficiency and speed to improve clinical decision making and positively impact patients' lives."

Philips is also working on expanding the menu of tests it offers on its Minicare system, a blood analyzer with single-use, disposable cartridges for each test. It already has a Minicare test for acute coronary syndrome on the market and teamed up with Janssen in March last year to develop a test for brain disorders. In January, the Dutch company struck a deal with Banyan Biomarkers to develop a Minicare test for traumatic brain injury.

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.